Eton Pharmaceuticals

(NASDAQ) ETON

Current Price$29.19

Market Cap$797.94M

Since IPO (2018)+366%

5 Year+372%

1 Year+69%

1 Month-3%

Eton Pharmaceuticals Financials at a Glance

Market Cap

$797.94M

Revenue (TTM)

$86.93M

Net Income (TTM)

-$1.48M

EPS (TTM)

-$0.07

P/E Ratio

-410.28

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$29.19

Volume

239,301.112

Open

$29.03

Price

$29.19

Volume

239,301.112

Open

$29.03

Previous Close

$29.13

Daily Range

$28.41 - $29.76

52-Week Range

$13.09 - $35.66

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$29.19

Volume

239,301.112

Open

$29.03

Previous Close

$29.13

Daily Range

$28.41 - $29.76

52-Week Range

$13.09 - $35.66

Estimated Earnings Date

Aug 6, 2026

ETON News

Eton (ETON) Q2 Revenue Jumps 108%

Motley Fool Markets TeamAug 7, 2025

ETON: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eton Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sean E. Brynjelsen, MBA

Website

www.etonpharma.com

Headquarters

Deer Park, IL 60010-7208, US

ETON Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

Net Income Margin

-2%

Return on Equity

-5%

Return on Capital

Return on Assets

-2%

Earnings Yield

-0.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$797.94M

Shares Outstanding

27.39M

Volume

239.30K

Avg. Volume

424.34K

Financials (TTM)

Gross Profit

$42.74M

Operating Income

$72.00K

EBITDA

$4.12M

Operating Cash Flow

$10.52M

Capital Expenditure

-$333.00K

Free Cash Flow

$10.19M

Cash & ST Invst.

$25.94M

Total Debt

$31.02M

Eton Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$24.27M

+40.4%

Gross Profit

$14.74M

+49.4%

Gross Margin

60.72%

N/A

Market Cap

$797.94M

N/A

Market Cap/Employee

$25.74M

N/A

Employees

N/A

Net Income

$1.55M

+198.9%

EBITDA

$2.41M

+344.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$7.41M

+158.6%

Accounts Receivable

$13.41M

-18.2%

Inventory

$14.47M

+6.2%

Long Term Debt

$440.00K

-98.5%

Short Term Debt

$11.81M

N/A

Return on Assets

-1.51%

N/A

Return on Invested Capital

3.81%

N/A

Free Cash Flow

$7.33M

+250.7%

Operating Cash Flow

$7.41M

+254.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.91+0.53%

OMEROmeros Corporation

OMEROmeros Corporation$9.79-4.49%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.28-6.57%

MNPRMonopar Therapeutics Inc.

MNPRMonopar Therapeutics Inc.$59.48-0.22%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$1.63-6.86%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$4.20-1.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About ETON

What is the current price of Eton Pharmaceuticals?

Eton Pharmaceuticals is trading at $29.13 per share.

What is the 52-week range for Eton Pharmaceuticals?

Over the past 52 weeks, Eton Pharmaceuticals has traded between $13.09 and $35.66.

How much debt does Eton Pharmaceuticals have?

As of the most recent reporting period, Eton Pharmaceuticals reported total debt of $31.26M.

How much cash does Eton Pharmaceuticals have on hand?

Eton Pharmaceuticals reported $19.66M in cash and cash equivalents in its most recent financial results.

What is Eton Pharmaceuticals’s dividend yield?

Eton Pharmaceuticals does not currently have a dividend yield.

Eton Pharmaceuticals

Eton Pharmaceuticals Financials at a Glance

ETON News

Eton (ETON) Q2 Revenue Jumps 108%

ETON: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Eton Pharmaceuticals

ETON Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Eton Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ETON

What is the current price of Eton Pharmaceuticals?

What is the 52-week range for Eton Pharmaceuticals?

How much debt does Eton Pharmaceuticals have?

How much cash does Eton Pharmaceuticals have on hand?

What is Eton Pharmaceuticals’s dividend yield?

Premium Investing Services